{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:28:20Z","timestamp":1792218500922,"version":"4.4.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1053\/j.seminoncol.2013.09.013","type":"journal-article","created":{"date-parts":[[2013,12,11]],"date-time":"2013-12-11T15:46:08Z","timestamp":1386776768000},"page":"666-675","source":"Crossref","is-referenced-by-count":172,"title":["Therapy-Related Myelodysplasia and Acute Myeloid Leukemia"],"prefix":"10.1053","volume":"40","author":[{"given":"Smita","family":"Bhatia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2013.09.013_bib1","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1093\/jnci\/85.23.1932","article-title":"Second cancers among long-term survivors of non-Hodgkin\u2019s lymphoma","volume":"85","author":"Travis","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib2","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/jnci\/87.10.732","article-title":"Incidence of second cancers in patients treated for Hodgkin\u2019s disease","volume":"87","author":"Boivin","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib3","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM199603213341201","article-title":"Breast cancer and other second neoplasms after childhood Hodgkin's disease","volume":"334","author":"Bhatia","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib4","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1056\/NEJM199112123252402","article-title":"Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia","volume":"325","author":"Pui","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib5","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199111073251902","article-title":"Second neoplasms after acute lymphoblastic leukemia in childhood","volume":"325","author":"Neglia","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1182\/blood-2006-01-023101","article-title":"Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: a report from the Children's Oncology Group","volume":"109","author":"Bhatia","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib7","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1182\/blood.V99.12.4257","article-title":"Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983","volume":"99","author":"Bhatia","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib8","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/jnci\/92.14.1165","article-title":"Treatment-associated leukemia following testicular cancer","volume":"92","author":"Travis","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJM199902043400504","article-title":"Risk of leukemia after platinum-based chemotherapy for ovarian cancer","volume":"340","author":"Travis","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib10","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1182\/blood.V87.9.3633.bloodjournal8793633","article-title":"Malignant neoplasms following bone marrow transplantation","volume":"87","author":"Bhatia","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.bmt.1704124","article-title":"Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma","volume":"32","author":"Howe","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib12","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1182\/blood.V95.5.1588.005k38_1588_1593","article-title":"Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors","volume":"95","author":"Krishnan","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib13","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1182\/blood.V83.12.3437.3437","article-title":"Myelodysplastic syndrome after autologous transplantation for lymphoma: the price of progress?","volume":"83","author":"Stone","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib14","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1182\/blood.V84.3.957.957","article-title":"Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin disease and non-Hodgkin lymphoma","volume":"84","author":"Traweek","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib15","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1182\/blood.V91.12.4496","article-title":"Predictive value of clonality assays in patients with non-Hodgkin\u2019s lymphoma undergoing autologous bone marrow transplant: a single institution study","volume":"91","author":"Mach-Pascual","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib16","first-page":"1933","article-title":"Treatment-related deaths and second cancer risk after autologous stem cell transplantation for Hodgkin\u2019s disease","volume":"92","author":"Andre","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib17","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1200\/JCO.1998.16.3.1008","article-title":"Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant","volume":"16","author":"Laughlin","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib18","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1200\/JCO.1998.16.10.3386","article-title":"Secondary leukemia following cumulative doses of etoposide in patients treated for advanced germ cell tumors","volume":"16","author":"Kollmannsberger","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1365-2141.1996.d01-1891.x","article-title":"Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myeloma","volume":"95","author":"Govindarajan","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib20","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/sj.leu.2400809","article-title":"High risk of therapy-related leukemia after BEAM chemotherapy and autologous stem cell transplantation for previously treated lymphomas is mainly related to primary chemotherapy and not to BEAM-transplantation procedure","volume":"11","author":"Pedersen-Bjergaard","year":"1997","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1053\/bbmt.2002.v8.pm11846355","article-title":"Evaluation of the risk of therapy-related MDS\/AML after autologous stem cell transplantation","volume":"8","author":"Gilliland","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib22","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1046\/j.1365-2141.1999.01627.x","article-title":"Secondary leukemia and myelodysplasia after autografting for lymphoma: results from the EBMT","volume":"106","author":"Milligan","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/10428190109097649","article-title":"Incidence of post-transplant myelodysplasia\/acute leukemia in non-Hodgkin\u2019s lymphoma patients compared with Hodgkin\u2019s disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV)","volume":"40","author":"Wheeler","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib24","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1200\/JCO.1986.4.3.325","article-title":"Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes 5 and 7","volume":"4","author":"Le Beau","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0272-2712(18)30077-5","article-title":"Therapy-related acute leukemia","volume":"20","author":"Karp","year":"2000","journal-title":"Clin Lab Med"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib27","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1182\/blood.V99.6.1909","article-title":"Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia","volume":"99","author":"Pedersen-Bjergaard","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib28","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood.V78.4.1147.1147","article-title":"Balanced translocation involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II","volume":"78","author":"Pedersen-Bjergaard","year":"1991","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib29","unstructured":"van Leeuwen FE, Travis LB Second cancers. In: Cancer: principles and practice of oncology (7th ed). Philadelphia: Lippincott Williams & Wilkins; 2005:2575-602."},{"key":"10.1053\/j.seminoncol.2013.09.013_bib30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ijc.1021","article-title":"Two metachronous tumors in the radiotherapy fields of a patient with Li-Fraumeni syndrome","volume":"96","author":"Limacher","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/cncr.11046","article-title":"Cancer in Fanconi anemia, 1927-2001","volume":"97","author":"Alter","year":"2003","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2141.2004.05023.x","article-title":"Fanconi anaemia and leukaemia\u2014clinical and molecular aspects","volume":"126","author":"Tischkowitz","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib33","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3324\/haematol.12234","article-title":"Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry","volume":"93","author":"Rosenberg","year":"2008","journal-title":"Haematologica"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib34","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1101\/gad.1370505","article-title":"The Fanconi Anemia\/BRCA pathway: new faces in the crowd","volume":"19","author":"Kennedy","year":"2005","journal-title":"Genes Dev"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0009-9236(99)70006-8","article-title":"The science of pharmacological variability: an essay","volume":"66","author":"Kalow","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib36","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1056\/NEJMra020526","article-title":"Pharmacogenomics\u2014drug disposition, drug targets, and side effects","volume":"348","author":"Evans","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib37","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/jnci\/92.11.874","article-title":"Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review","volume":"92","author":"Berwick","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib38","first-page":"1513","article-title":"Polymorphisms in DNA repair genes and associations with cancer risk","volume":"11","author":"Goode","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib39","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1158\/1055-9965.EPI-08-0300","article-title":"Breast cancer risk polymorphisms and interaction with ionizing radiation among U.S. radiologic technologists","volume":"17","author":"Bhatti","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib40","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ijc.23066","article-title":"Polymorphisms in DNA repair genes, ionizing radiation exposure and risk of breast cancer in U.S Radiologic technologists","volume":"122","author":"Bhatti","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib41","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1002\/ijc.23779","article-title":"Nucleotide excision repair polymorphisms may modify ionizing radiation-related breast cancer risk in US radiologic technologists","volume":"123","author":"Rajaraman","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib42","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1158\/1535-7163.363.3.3","article-title":"Cytochrome P450 enzymes: novel options for cancer therapeutics","volume":"3","author":"McFadyen","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib43","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1073\/pnas.93.6.2322","article-title":"Induction of cytochrome P4501A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin or indolo(3,2-b)carbazole is associated with oxidative DNA damage","volume":"93","author":"Park","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev.pharmtox.45.120403.095857","article-title":"Glutathione transferases","volume":"45","author":"Hayes","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib45","doi-asserted-by":"crossref","first-page":"11592","DOI":"10.1073\/pnas.191211198","article-title":"Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia","volume":"98","author":"Allan","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib46","first-page":"4091","article-title":"Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia\/myelodysplastic syndrome and de novo acute myeloid leukemia","volume":"6","author":"Naoe","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib47","doi-asserted-by":"crossref","first-page":"13176","DOI":"10.1073\/pnas.95.22.13176","article-title":"Association of CYP3A4 genotype with treatment-related leukemia","volume":"95","author":"Felix","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib48","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1365-2141.2006.06469.x","article-title":"Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia","volume":"136","author":"Bolufer","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib49","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/sj.leu.2403947","article-title":"Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients","volume":"19","author":"Rund","year":"2005","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib50","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/mutage\/17.6.489","article-title":"Repair of oxidative DNA damage: assessing its contribution to cancer prevention","volume":"17","author":"Collins","year":"2002","journal-title":"Mutagenesis"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib51","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.biochi.2003.10.007","article-title":"Human mismatch repair, drug-induced DNA damage, and secondary cancer","volume":"85","author":"Karran","year":"2003","journal-title":"Biochimie"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib52","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1568-7864(03)00020-X","article-title":"Drug treatment in the development of mismatch repair defective acute leukemia and myelodysplastic syndrome","volume":"2","author":"Casorelli","year":"2003","journal-title":"DNA Repair (Amst)"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/sj.leu.2402747","article-title":"Methylation of the hMLH1 promoter and its association with microsatellite instability in acute myeloid leukemia","volume":"17","author":"Seedhouse","year":"2003","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib54","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1182\/blood.V94.2.733","article-title":"Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult acute leukemia","volume":"94","author":"Zhu","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib55","first-page":"3012","article-title":"An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agents","volume":"9","author":"Worrillow","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib56","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/sj.leu.2401466","article-title":"Distinct genetic involvement of the TP53 gene in therapy-related leukemia and myelodysplasia with chromosomal losses of Nos 5 and\/or 7 and its possible relationship to replication error phenotype","volume":"13","author":"Horiike","year":"1999","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib57","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0092-8674(93)90546-3","article-title":"The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer","volume":"75","author":"Fishel","year":"1993","journal-title":"Cell"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib58","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0016-5085(95)90280-5","article-title":"A germline substitution in the human MSH2 gene is associated with high-grade dysplasia and cancer in ulcerative colitis","volume":"109","author":"Brentnall","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib59","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1038\/sj.onc.1209208","article-title":"Deregulation of homologous recombination DNA repair in alkylating agent-treated stem cell clones: a possible role in the aetiology of chemotherapy-induced leukaemia","volume":"25","author":"Worrillow","year":"2006","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib60","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrg1746","article-title":"The role of double-strand break repair\u2014insights from human genetics","volume":"7","author":"O'Driscoll","year":"2006","journal-title":"Nat Rev Genet"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib61","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0968-0004(98)01232-8","article-title":"Role of the human RAD51 protein in homologous recombination and double-stranded-break repair","volume":"23","author":"Baumann","year":"1998","journal-title":"Trends Biochem Sci"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib62","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1182\/blood-2006-05-022921","article-title":"Polymorphisms in human homeobox HLX1 and DNA repair RAD51 genes increase the risk of therapy-related acute myeloid leukemia","volume":"108","author":"Jawad","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib63","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1158\/1078-0432.CCR-03-0372","article-title":"Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia","volume":"10","author":"Seedhouse","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib64","doi-asserted-by":"crossref","first-page":"21482","DOI":"10.1074\/jbc.273.34.21482","article-title":"Xrcc3 is required for assembly of Rad51 complexes in vivo","volume":"273","author":"Bishop","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib65","doi-asserted-by":"crossref","first-page":"6354","DOI":"10.1073\/pnas.92.14.6354","article-title":"Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene","volume":"92","author":"Tebbs","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib66","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1101\/gad.13.20.2633","article-title":"XRCC3 promotes homology-directed repair of DNA damage in mammalian cells","volume":"13","author":"Pierce","year":"1999","journal-title":"Genes Dev"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib67","first-page":"604","article-title":"Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans","volume":"58","author":"Shen","year":"1998","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib68","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/carcin\/22.9.1437","article-title":"XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects","volume":"22","author":"Matullo","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib69","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1289\/ehp.6632","article-title":"Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays","volume":"111","author":"Au","year":"2003","journal-title":"Environ Health Perspect"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib70","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/MCB.14.1.68","article-title":"An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III","volume":"14","author":"Caldecott","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib71","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1002\/j.1460-2075.1996.tb01056.x","article-title":"Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein","volume":"15","author":"Kubota","year":"1996","journal-title":"EMBO J"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib72","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1182\/blood-2002-04-1152","article-title":"The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia","volume":"100","author":"Seedhouse","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib73","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood-2004-06-2161","article-title":"Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy","volume":"104","author":"Allan","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib74","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1182\/blood.V95.11.3273","article-title":"Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation","volume":"95","author":"Pedersen-Bjergaard","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib75","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.1200\/JCO.2005.10.330","article-title":"Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphoma","volume":"23","author":"Bhatia","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib76","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0027-5107(96)00021-8","article-title":"Mutagenic damage to mammalian cells by therapeutic alkylating agents","volume":"355","author":"Sanderson","year":"1996","journal-title":"Mutat Res"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib77","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1021\/tx00035a001","article-title":"When good enzymes go bad: conversion of topoisomerase II to a cellular toxin by antineoplastic drugs","volume":"6","author":"Corbett","year":"1993","journal-title":"Chem Res Toxicol"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib78","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1021\/bi002361x","article-title":"Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpoints","volume":"40","author":"Lovett","year":"2001","journal-title":"Biochemistry"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib79","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1073\/pnas.050397097","article-title":"Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors","volume":"97","author":"Megonigal","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib80","first-page":"4287","article-title":"Chromosome band 11q23 translocation breakpoints are DNA topoisomerase II cleavage site","volume":"55","author":"Felix","year":"1995","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib81","first-page":"226","article-title":"Human trithorax gene rearrangements in therapy-related acute leukemia after etoposide treatment","volume":"8","author":"Bower","year":"1994","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib82","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1182\/blood.V87.5.1912.1912","article-title":"Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and therapy-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites","volume":"87","author":"Broeker","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib83","article-title":"Chromosomal abnormalities in secondary MDS and AML: relationship to drugs and radiation with specific emphasis on the balanced rearrangements","volume":"83","author":"Andersen","year":"1998","journal-title":"Haematologica"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib84","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1182\/blood.V88.11.4296.bloodjournal88114296","article-title":"Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype","volume":"88","author":"Ben-Yehuda","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib85","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1200\/JCO.2001.19.5.1405","article-title":"Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis","volume":"19","author":"Christiansen","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib86","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1182\/blood-2007-11-126508","article-title":"MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility","volume":"112","author":"Ellis","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib87","first-page":"e58","article-title":"Genetic susceptibility to therapy-related leukemia after Hodgkin lymphoma or non-Hodgkin lymphoma: role of drug metabolism, apoptosis, and DNA repair","volume":"2","author":"Ding","year":"2012","journal-title":"BCJ"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib88","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/350569a0","article-title":"Structure and function of telomeres","volume":"266","author":"Blackburn","year":"1991","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib89","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0092-8674(01)00457-3","article-title":"Telomere dysfunction increases mutation rate and genomic instability","volume":"106","author":"Hackett","year":"2001","journal-title":"Cell"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib90","doi-asserted-by":"crossref","first-page":"9857","DOI":"10.1073\/pnas.91.21.9857","article-title":"Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age","volume":"91","author":"Vaziri","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib91","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1200\/JCO.2008.17.1033","article-title":"Accelerated telomere shortening in hematopoietic cells preceding development of therapy-related myelodysplasia or acute myeloid leukemia (t-MDS\/AML) after autologous transplantation for lymphoma","volume":"27","author":"Chakraborty","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib92","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1200\/JCO.1999.17.10.3128","article-title":"Outcome of patients with myelodysplastic syndrome after autologous bone marrow transplantation for non- Hodgkin\u2019s lymphoma","volume":"17","author":"Friedberg","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib93","first-page":"1085","article-title":"Allogeneic bone marrow transplantation for secondary leukemia or myelodysplasia","volume":"84","author":"Witherspoon","year":"1999","journal-title":"Haematologica"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib94","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.2000.18.5.963","article-title":"Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients. Report of the French society of bone marrow transplantation","volume":"18","author":"Yakoub-Agha","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib95","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood.V89.7.2578","article-title":"Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy","volume":"89","author":"Anderson","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib96","first-page":"33","article-title":"Secondary leukemia","author":"Appelbaum","year":"1996","journal-title":"Hematology Am Soc Hematol Educ Prog"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib97","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1200\/JCO.1993.11.12.2370","article-title":"Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature","volume":"11","author":"Quesnel","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib98","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1200\/JCO.2001.19.8.2134","article-title":"Hematopoietic stem-cell transplantation for treatment related leukemia or myelodysplasia","volume":"19","author":"Witherspoon","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib99","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/ajh.20939","article-title":"Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: no impact on early mortality and intracranial hemorrhage","volume":"82","author":"Chang","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib100","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.bbmt.2007.01.079","article-title":"Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation","volume":"13","author":"Armand","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib101","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3324\/haematol.2008.000927","article-title":"Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation","volume":"94","author":"Kroger","year":"2009","journal-title":"Haematologica"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib102","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1182\/blood-2009-10-249128","article-title":"Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia","volume":"115","author":"Litzow","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib103","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2001.19.9.2472","article-title":"Detection of chromosome abnormalities pre-high dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non- Hodgkin\u2019s lymphoma","volume":"19","author":"Lillington","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib104","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1535-6108(02)00032-6","article-title":"Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling","volume":"1","author":"Yeoh","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib105","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ccr.2011.09.011","article-title":"Altered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia\/acute myeloid leukemia and identifies patients at risk","volume":"20","author":"Li","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib106","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1046\/j.1365-2141.1999.01627.x","article-title":"Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation","volume":"106","author":"Milligan","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2013.09.013_bib107","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1200\/JCO.2012.44.5791","article-title":"Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials","volume":"31","author":"Koontz","year":"2013","journal-title":"J Clin Oncol"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775413001711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775413001711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T22:35:13Z","timestamp":1688855713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775413001711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":107,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0093775413001711"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2013.09.013","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}